Search by Drug Name or NDC
NDC 24385-0072-82 GNP Caldyphen 10; 80 mg/mL; mg/mL Details
GNP Caldyphen 10; 80 mg/mL; mg/mL
GNP Caldyphen is a TOPICAL LOTION in the HUMAN OTC DRUG category. It is labeled and distributed by Amerisource Bergen. The primary component is PRAMOXINE HYDROCHLORIDE; ZINC OXIDE.
Product Information
| NDC | 24385-0072 |
|---|---|
| Product ID | 24385-072_0c81fa69-5856-a37e-e063-6394a90a19c6 |
| Associated GPIs | 90859902934120 |
| GCN Sequence Number | 022061 |
| GCN Sequence Number Description | pramoxine HCl/calamine LOTION 1 %-8 % TOPICAL |
| HIC3 | L3P |
| HIC3 Description | ANTIPRURITICS,TOPICAL |
| GCN | 65328 |
| HICL Sequence Number | 010079 |
| HICL Sequence Number Description | PRAMOXINE HCL/CALAMINE |
| Brand/Generic | Generic |
| Proprietary Name | GNP Caldyphen |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calamine and Pramoxine Hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOTION |
| Route | TOPICAL |
| Active Ingredient Strength | 10; 80 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | PRAMOXINE HYDROCHLORIDE; ZINC OXIDE |
| Labeler Name | Amerisource Bergen |
| Pharmaceutical Class | Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M016 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24385-0072-82 (24385007282)
| NDC Package Code | 24385-072-82 |
|---|---|
| Billing NDC | 24385007282 |
| Package | 177 mL in 1 BOTTLE, PLASTIC (24385-072-82) |
| Marketing Start Date | 2013-06-28 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.01389 |
| Pricing Unit | ML |
| Effective Date | 2024-01-17 |
| NDC Description | CALDYPHEN LOTION |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis